Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.32
0.0000
Volume:15
Turnover:502.54
Market Cap:13.33M
PE:- -
High:33.32
Open:33.32
Low:33.32
Close:33.32
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.04
T/O Rate:0.00%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

US FDA Approves Scholar Rock's Muscle Weakness Drug

Reuters
·
Sep 12

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
Sep 12

Pharming wins FDA nod to extend Joenja use to younger APDS children

TIPRANKS
·
Sep 12

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Sep 12

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
Sep 12

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Edwards Lifesciences Price Target Maintained with a $110.00/Share by BTIG

Dow Jones
·
Sep 11

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH) and Edwards Lifesciences (EW)

TIPRANKS
·
Sep 11

Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

Shenyang Xingqi Gains Nod for Eye Drop Candidate Clinical Study

Stock News
·
Sep 11

The Race for the Next Big Weight-Loss Drug is On-and China Wants In

Dow Jones
·
Sep 11

Edwards Lifesciences comments on TAVR national coverage decision

TIPRANKS
·
Sep 11

Edwards Lifesciences Welcomes CMS Update to Medicare TAVR Coverage Policy

Reuters
·
Sep 11

Edwards Lifesciences Corporation - Maintains Confidence in Financial Guidance for 2026

THOMSON REUTERS
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11